Sustained proton-pump inhibitor exposure and incident age-related macular degeneration: a new-user, population-based cohort study.
OBJECTIVE: Proton-pump inhibitors (PPIs) may disrupt lysosomal acidification, a pathway implicated in age-related macular degeneration (AMD) pathogenesis. The consistency of the active-comparator findings supports the potential specificity of this association and warrants further investigation to determine its clinical implications.
OBJECTIVE: Proton-pump inhibitors (PPIs) may disrupt lysosomal acidification, a pathway implicated in age-related macular degeneration (AMD) pathogenesis. The consistency of the active-comparator findings supports the potential specificity of this association and warrants further investigation to determine its clinical implications.
What the study was
- Study design
- Cohort Study
- Category
- Treatment Innovation
- Maturity
- Validated
- Journal
- BMJ open ophthalmology
Why it surfaced
Score 8/10: Cohort Study matching topic 'Cardiovascular-metabolic GLP-1 SGLT2'
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.